Trial intelligence / Profile preview

Testosterone-related pelvic organ and sexual function MRI study in transmasculine and gender-diverse adults

NL-OMON57385Recruiting

Sponsor
Vrije University Medical Center
Start
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of testosterone in gender dysphoria (GD), sponsored by Vrije University Medical Center. Primary endpoints: Clitoral volume before and after testosterone, Pelvic floor musculature volume before and after testosterone and 2 more. Started Aug 2025; status: recruiting.

02

Drugs

testosterone
03

Conditions

gender dysphoria (GD)

Beyond the preview

Go deeper on NL-OMON57385.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON57385.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call